[Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
After a review of the pathogenesis of congestive decompensation in the light of recent discoveries, the basis for the use of vasodilator drugs in such pathologies is discussed. The results of personal clinical experiments using hydralazine and isosorbide dinitrate are described with the conclusion that these drugs are really effective.
D001794:Blood Pressure / Q000187:drug effects; D006332:Cardiomegaly / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002908:Chronic Disease; D004341:Drug Evaluation; D006321:Heart / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D007548:Isosorbide Dinitrate / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D006830:Hydralazine; D007548:Isosorbide Dinitrate
I farmaci vasodilatatori nella terapia dello scompenso di cuore cronico congestizio. Contributo clinico-casistico.